CRISPR/Cas9-mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell-derived cardiomyocytes
John W. Ostrominski(Brigham and Women's Hospital), Cynthia E. Dunbar(National Institutes of Health), Mark C. Haigney(Uniformed Services University of the Health Sciences), Hong San(National Institutes of Health), Noriko Sato(National Cancer Institute), Manfred Boehm(National Heart Lung and Blood Institute), Yongshun Lin(University of Michigan–Ann Arbor), Falguni Basuli, Racquel Valadez(Center for Cancer Research), So Gun Hong(National Institutes of Health), Rolf E. Swenson, Dakshesh Patel(United States Food and Drug Administration), Kah-Whye Peng(Mayo Clinic), Ksenia Blinova(United States Food and Drug Administration), Ravi Chandra Yada(National Institutes of Health), Peter L. Choyke(National Cancer Institute), Xiang Zhang(First Affiliated Hospital of Wenzhou Medical University), Michael G. Klein(Uniformed Services University of the Health Sciences), Jizhong Zou(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Maryknoll Palisoc(Center for Cancer Research), Stefania Pittaluga(Cancer Institute (WIA))
Cited by 16
Related Papers
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
|Nature Genetics|1997|1.5k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k
Gene therapy comes of age
|Science|2018|1.4k
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
|Nature Medicine|2015|1.1k